797804-50-3 Usage
Uses
Used in Biochemical Research:
METHYL 3-FORMYL-1H-INDAZOLE-5-CARBOXYLATE is used as a research compound for studying its chemical properties and potential interactions with biological systems. Its unique structure allows for exploration in various scientific applications.
Used in Organic Synthesis:
METHYL 3-FORMYL-1H-INDAZOLE-5-CARBOXYLATE is used as a synthetic building block in the preparation of more complex organic molecules. Its versatility in chemical reactions makes it a valuable component in the synthesis of various compounds.
Used in Pharmaceutical Industry:
METHYL 3-FORMYL-1H-INDAZOLE-5-CARBOXYLATE is used as a pharmaceutical intermediate in the development of new drugs. Its bioactive nature contributes to the discovery of potential therapeutic agents for various medical conditions.
Used in Drug Discovery:
METHYL 3-FORMYL-1H-INDAZOLE-5-CARBOXYLATE is used as a key component in the design and synthesis of new drug candidates. Its presence in the molecular structure can influence the pharmacological properties and therapeutic potential of the final drug product.
Check Digit Verification of cas no
The CAS Registry Mumber 797804-50-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,7,8,0 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 797804-50:
(8*7)+(7*9)+(6*7)+(5*8)+(4*0)+(3*4)+(2*5)+(1*0)=223
223 % 10 = 3
So 797804-50-3 is a valid CAS Registry Number.
797804-50-3Relevant articles and documents
Anti-inflammatory agents
-
Page/Page column 93; 94, (2016/02/05)
Disclosed are novel compounds that are useful in regulating the expression of interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1), and their use in the treatment and/or prevention of cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s). Also, disclosed are compositions comprising the novel compounds, as well as methods for their preparation.
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
Paragraph 0573, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.
